Cargando…

Oxidative damage to DNA: do we have a reliable biomarker?

Oxidized bases in DNA can be measured directly by high-performance liquid chromatography (HPLC). 7,8-Dihydro-8-oxo-guanine (8-OHgua), as the most abundant oxidation product, is often regarded as an indicator of oxidative stress. Estimates of endogenous 8-OHgua levels in human lymphocyte DNA are betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, A R, Dusinská, M, Gedik, C M, Stĕtina, R
Formato:	Texto
Lenguaje:	English
Publicado:	1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1469644/ https://www.ncbi.nlm.nih.gov/pubmed/8781365

Ejemplares similares

Commentary: Systemic immune-inflammatory indices and their association with ocular disorders—Do we have economical and reliable biomarkers?
por: Madanagopalan, V G
Publicado: (2020)

Do We Have the Spark?
por: Rupel, Valentina Prevolnik, et al.
Publicado: (2022)

The Reliability and Predictive Ability of a Biomarker of Oxidative DNA Damage on Functional Outcomes after Stroke Rehabilitation
por: Hsieh, Yu-Wei, et al.
Publicado: (2014)

Why Do We Have Fingerprints?
Publicado: (2009)

Premature ejaculation: do we have effective therapy?
por: Serefoglu, Ege Can, et al.
Publicado: (2013)

Antibiotic Discovery: Where Have We Come from, Where Do We Go?
por: Ribeiro da Cunha, Bernardo, et al.
Publicado: (2019)

Response to DNA damage: why do we need to focus on protein phosphatases?
por: Shimada, Midori, et al.
Publicado: (2013)

Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?
por: Wezel, Felix, et al.
Publicado: (2017)

Human preleukaemia: do we have a model?
por: Jacobs, A.
Publicado: (1987)

Drugs for malaria elimination: what do we have now and what do we need?
por: Shanks, Dennis
Publicado: (2014)

INDIAN PSYCHIATRY AT THE CROSSROADS - WHAT WE CAN DO WITH WHAT WE HAVE?1
por: Channabasavanna, S.M.
Publicado: (1992)

Biomaterials for Testicular Bioengineering: How far have we come and where do we have to go?
por: Horvath-Pereira, Bianca de Oliveira, et al.
Publicado: (2023)

Do we have a diabetes epidemic in Libya?
por: Bakoush, Omran, et al.
Publicado: (2006)

Do we have to reconsider the evolutionary emergence of myelin?
por: Werner, Hauke B.
Publicado: (2013)

Do We Have a Channel Solution for ALS?
por: de Carvalho, Mamede
Publicado: (2015)

'We will have a lot to do when this is over'
por: Subbaraman, Pramod
Publicado: (2020)

Presbycusis: do we have a third ear?()
por: Reis, Luis Roque, et al.
Publicado: (2016)

Infectious diseases and cognition: do we have to worry?
por: Hernandez-Ruiz, Virgilio, et al.
Publicado: (2022)

Neonatal pain assessment: Do we have the right tools?
por: Llerena, Amelia, et al.
Publicado: (2023)

Treatment options for small cell lung cancer – do we have more choice?
por: Puglisi, M, et al.
Publicado: (2010)

Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
por: Górriz, Jose Luis, et al.
Publicado: (2015)

Augmented Renal Clearance: What Have We Known and What Will We Do?
por: Luo, Yifan, et al.
Publicado: (2021)

Plain packaging of cigarettes: do we have sufficient evidence?
por: Smith, Collin N, et al.
Publicado: (2015)

Biomarkers in critical illness: have we made progress?
por: Honore, Patrick M, et al.
Publicado: (2016)

Oxidative Damage to DNA and Lipids as Biomarkers of Exposure to Air Pollution
por: Møller, Peter, et al.
Publicado: (2010)

Sleep-Disordered Breathing—Do We Have to Change Gears in Heart Failure?
por: Cowie, Martin R.
Publicado: (2016)

Do We Have Real Poverty in the United States of America?
por: Braveman, Paula
Publicado: (2007)

Congenital myelomeningocele – do we have to change our management?
por: Mayer, Steffi, et al.
Publicado: (2010)

Why Do We have to Move Fluid to be Able to Breathe?
por: Fronius, Martin, et al.
Publicado: (2012)

Why do we not have a cure for rheumatoid arthritis?
por: El-Gabalawy, Hani D, et al.
Publicado: (2002)

Congenital myelomeningocele - do we have to change our management?
por: Mayer, Steffi, et al.
Publicado: (2010)

How do we have to operate the LHCb spectrometer magnet?
por: Herr, Werner, et al.
Publicado: (2008)

Do we have an opioid crisis in Scandinavia? Time to act?
por: Heilig, Marcus, et al.
Publicado: (2018)

Open questions: How many genes do we have?
por: Salzberg, Steven L.
Publicado: (2018)

Sex Differences in Science: Do We Have a Problem?
por: van Rooij, Eva, et al.
Publicado: (2019)

The diagnosis of premenstrual mood disorders: Do we have it backwards?
por: Phillips, Nancy
Publicado: (2019)

We Have to Talk: “Doing” Critical Literacy in Class and in Community
por: Pearson, Rebecca L.
Publicado: (2017)

Cap-assisted endoscopy: Do we have enough evidence?
por: Frieling, Thomas
Publicado: (2018)

Cardiology and COVID-19: do we have sufficient information?
por: Garg, Nikita, et al.
Publicado: (2020)

Asthma and COVID-19: do we finally have answers?
por: Eger, Katrien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k53rm17d42ig6k2lcce2fbkpe6